Leveraging CRISPR-Cas9 Technology for Biopharmaceutical Development: Challenges and Market Opportunities

被引：0
|
作者：
Anderson, Angela [1 ]
机构：
[1] Wellington Institute of Technology, New Zealand
来源：
Journal of Commercial Biotechnology | 2024年 / 29卷 / 04期
关键词：
Compendex;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cost engineering
引用
收藏
页码：23 / 31
相关论文
共 50 条
  • [21] Exploring the potential of genome editing CRISPR-Cas9 technology
    Singh, Vijai
    Braddick, Darren
    Dhar, Pawan Kumar
    GENE, 2017, 599 : 1 - 18
  • [22] Genome editing by CRISPR-Cas9 technology in Petunia hybrida
    Chopy, M.
    Morel, P.
    Bento, S. Rodrigues
    Vandenbussche, M.
    XXVI INTERNATIONAL EUCARPIA SYMPOSIUM SECTION ORNAMENTALS: EDITING NOVELTY, 2020, 1283 : 209 - 217
  • [23] Editorial: Precision oncology in the era of CRISPR-Cas9 technology
    Khalil, Athar
    FRONTIERS IN GENETICS, 2024, 15
  • [24] Precision Plant Breeding Using CRISPR-Cas9 Technology
    Svitashev, S.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2018, 54 : S18 - S18
  • [25] Research Progress on CRISPR-Cas9 Technology to Modify Lactobacillus
    Yu Y.
    Liu H.
    Science and Technology of Food Industry, 2022, 43 (21) : 461 - 470
  • [26] CRISPR-Cas9 technology and its application in haematological disorders
    Zhang, Han
    McCarty, Nami
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (02) : 208 - 225
  • [27] Bioethical issues in genome editing by CRISPR-Cas9 technology
    Ayanoglu, Fatma Betul
    Elcin, Ayse Eser
    Elcin, Yasar Murat
    TURKISH JOURNAL OF BIOLOGY, 2020, 44 (02) : 110 - 120
  • [28] CRISPR-Cas9 technology: applications and human disease modelling
    Torres-Ruiz, Raul
    Rodriguez-Perales, Sandra
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2017, 16 (01) : 4 - 12
  • [29] Correcting neuromuscular pathogenic variants with CRISPR-Cas9 technology
    Best, H.
    Woodman, K.
    Lek, A.
    Koczwara, K.
    Xu, E.
    Aykanat, A.
    Jiang, Y.
    Saltzman, M.
    Beggs, A.
    Lek, M.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S39 - S40
  • [30] Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research
    You, Liting
    Tong, Ruizhan
    Li, Mengqian
    Liu, Yuncong
    Xue, Jianxin
    Lu, You
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 13 : 359 - 370
12345